II
RCUS icon

Inspire Investing’s Arcus Biosciences RCUS Stock Holding History

Inspire Investing’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
386
+385
+38,500% +$9.52K ﹤0.01% 1114
2026
Q1 		$26 Sell
1
-1
-50% -$22 ﹤0.01% 1090
2025
Q4 		$45 Buy
+2
New +$41 ﹤0.01% 1080
2023
Q3 		– Sell
-15,318
Closed -$311K – 867
2023
Q2 		$311K Buy
15,318
+366
+2% +$6.97K 0.04% 766
2023
Q1 		$273K Buy
14,952
+3,531
+31% +$67.5K 0.03% 633
2022
Q4 		$236K Buy
11,421
+3,534
+45% +$97.2K 0.03% 458
2022
Q3 		$206K Buy
+7,887
New +$209K 0.03% 654

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Inspire Investing's RCUS Position: Q2 2026 in Review

Inspire Investing increased its Arcus Biosciences (RCUS) stake by 38,500% in Q2 2026, buying an estimated $9.52K and bringing the position to 386 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Inspire Investing first reported a position in RCUS in Q3 2022 and has held it in 7 quarters since. The position peaked at $311K in Q2 2023. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Inspire Investing held 386 shares of Arcus Biosciences worth $11.9K as of Q2 2026.
  • Inspire Investing bought 385 Arcus Biosciences shares in Q2 2026, an estimated $9.52K.
  • Arcus Biosciences made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1114 holding.
  • Inspire Investing first reported a position in Arcus Biosciences in Q3 2022 and has held it in 7 quarters since.
  • Inspire Investing's Arcus Biosciences position peaked at $311K in Q2 2023.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.